top of page
May 16, 20222 min read
ENGAGE THERAPEUTICS DOSES FIRST PATIENT IN PHASE 2B TRIAL OF EPILEPSY SEIZURE RESCUE THERAPY
ENGAGE THERAPEUTICS DOSES FIRST PATIENT IN PHASE 2B TRIAL OF EPILEPSY SEIZURE RESCUE THERAPY STACCATO® ALPRAZOLAM Topline Data Expected...
bottom of page